Change: 9.89 %Chge: 3.03% Vol: 59,425
REGN Chart
You need Flash Player to see the chart, please download from the link below
Related Healthcare and Pharmaceuticals Companies
| Stryker |
78.7
|
43,867 |
| Omnicare |
29.19
|
3,094,100 |
| Schein Henry |
70.9
|
39,845 |
| Forest Labs |
46.805
|
95,045 |
| Nuvasive |
33.34
|
49,881 |
| Becton Dickinson |
76.24
|
55,232 |
| Vca Antech |
49.26
|
36,280 |
| Baxter Intl |
58.79
|
220,990 |
Above is a small selection of related companies to Regeneron Pharmaceuticals which compete alongside REGN within the Healthcare and Pharmaceuticals sector. To see more related companies to REGN, view our stock market today information page.
Online News For Regeneron Pharmaceuticals
Interesting REGN Put And Call Options For February 2019
Investors in Regeneron Pharmaceuticals, Inc. (Symbol: REGN) saw new options become available this week, for the February 2019 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 240 ...
Nasdaq 100 Movers: JD, REGN
In early trading on Tuesday, shares of Regeneron Pharmaceuticals ( REGN) topped the list of the day's best performing components of the Nasdaq 100 index, trading up 1.9%. Year to date, Regeneron Pharmaceuticals has lost about 14.5% of its value. And the ...
Does Regeneron Pharmaceuticals, Inc. (REGN) Have Any Gas After Forming This Wedge Down Pattern?
Investors sentiment decreased to 1.05 in Q1 2018. Its down 0.12, from 1.17 in 2017Q4. It fall, as 70 investors sold Regeneron Pharmaceuticals, Inc. shares while 158 reduced holdings. 71 funds opened positions while 169 raised stakes. 69.33 million shares ...
Regeneron Pharmaceuticals (REGN) Presents At Goldman Sachs 39th Annual Global Healthcare Conference - Slideshow
The following slide deck was published by Regeneron Pharmaceuticals, Inc. in conjunction with this event. 134 Click to enlarge Notes:
Regeneron Pharmaceuticals (REGN) Shareholder Senzar Asset Management LLC Trimmed Holding by $17.81 Million
Investors sentiment decreased to 1.05 in Q1 2018. Its down 0.12, from 1.17 in 2017Q4. It fall, as 70 investors sold REGN shares while 158 reduced holdings. 71 funds opened positions while 169 raised stakes. 69.33 million shares or 0.23% more from 69.17 ...
Want To Add This Quote To Your Site?
With our stock widgets you can add a Regeneron Pharmaceuticals quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for REGN to choose from. Visit here to build your stock quote widget »
